Key Details
Price
$0.64Annual ROE
-82.11%Beta
0.70Events Calendar
Next earnings date:
Mar 27, 2025Recent quarterly earnings:
Nov 13, 2024Recent annual earnings:
Mar 27, 2024Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
Sep 3, 2024Analyst ratings
Recent major analysts updates
Oct 31, 24 Maxim Group
HoldJan 31, 23 HC Wainwright & Co.
BuyAug 13, 20 Aegis Capital
BuyJan 27, 20 Piper Sandler
OverweightJan 24, 20 SunTrust Robinson Humphrey
BuyJun 26, 19 HC Wainwright & Co.
BuyJun 26, 19 H.C. Wainwright
BuyMay 17, 19 BTIG Research
BuyMay 17, 19 BTIG
BuyFeb 11, 19 Roth Capital
BuyMarket Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price
Market cap
Technical
Dividend
Matinas BioPharma Holdings doesn't have historical dividend data
Profitability
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
Profit
EPS
ROA & ROE
EBIT & EBITDA
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Equity
Liabilities
Debt
Expenses
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cash Flow
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
Free CashFlow
CAPEX
Institutional Ownership
FAQ
- What is the ticker symbol for Matinas BioPharma Holdings?
- Does Matinas BioPharma Holdings pay dividends?
- What sector is Matinas BioPharma Holdings in?
- What industry is Matinas BioPharma Holdings in?
- What country is Matinas BioPharma Holdings based in?
- When did Matinas BioPharma Holdings go public?
- Is Matinas BioPharma Holdings in the S&P 500?
- Is Matinas BioPharma Holdings in the NASDAQ 100?
- Is Matinas BioPharma Holdings in the Dow Jones?
- When was Matinas BioPharma Holdings's last earnings report?
- When does Matinas BioPharma Holdings report earnings?
- Should I buy Matinas BioPharma Holdings stock now?
What is the ticker symbol for Matinas BioPharma Holdings?
The ticker symbol for Matinas BioPharma Holdings is NYSE American:MTNB
Does Matinas BioPharma Holdings pay dividends?
No, Matinas BioPharma Holdings does not pay dividends
What sector is Matinas BioPharma Holdings in?
Matinas BioPharma Holdings is in the Healthcare sector
What industry is Matinas BioPharma Holdings in?
Matinas BioPharma Holdings is in the Biotechnology industry
What country is Matinas BioPharma Holdings based in?
Matinas BioPharma Holdings is headquartered in United States
When did Matinas BioPharma Holdings go public?
Matinas BioPharma Holdings's initial public offering (IPO) was on July 21, 2014
Is Matinas BioPharma Holdings in the S&P 500?
No, Matinas BioPharma Holdings is not included in the S&P 500 index
Is Matinas BioPharma Holdings in the NASDAQ 100?
No, Matinas BioPharma Holdings is not included in the NASDAQ 100 index
Is Matinas BioPharma Holdings in the Dow Jones?
No, Matinas BioPharma Holdings is not included in the Dow Jones index
When was Matinas BioPharma Holdings's last earnings report?
Matinas BioPharma Holdings's most recent earnings report was on Nov 13, 2024
When does Matinas BioPharma Holdings report earnings?
The next expected earnings date for Matinas BioPharma Holdings is Mar 27, 2025
Should I buy Matinas BioPharma Holdings stock now?
As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions